基础信息
- 【通用名称】普瑞巴林口崩片
- 【英文名称】Pregabalin Orally Disintegrating Tablets
- 【汉语拼音】Puruibalin Koubengpian
- 【有效期】36个月
- 【批准文号】国药准字H20244251
- 【上市许可持有人】广州帝奇医药技术有限公司
details
- 【Indications】This product is used for the treatment of postherpetic neuralgia, fibromyalgia, and additional treatment of partial seizures in adults.
- 【Dosage】[Adverse Reactions], [Contraindications], [Precautions], etc. are detailed in the instructions
- 【Storage】Sealed, stored at no more than 30°C. Keep this product out of reach of children.
- 【Packaging】Polyvinyl chloride/polyvinylidene chloride solid pharmaceutical composite hard sheet and pharmaceutical aluminum foil. 10 tablets/plate.
产品特点
- 国际一线：国内外指南一线推荐用药。
- 创新剂型：无需水服、快速崩解，迅速起效。
- 广泛适用：老年人、卧床患者、急需用药场景。
- 安全可靠：相比液体制剂减少误吸、剂量精准。
- 市场空白：未被集采覆盖，渠道空间大。
top
